Valuing a hospital is nothing like valuing a factory: tangible assets are only part of it — licences, doctors and patient flows decide real value.
Valuation methods for medical facilities
Under the Price Law 2023 (16/2023/QH15), three approaches apply: market comparison (prices of comparable facility deals — hard, given few public transactions); income (discounted cash flows from visits and services — most common for well-run hospitals); cost (net asset value — fits new or loss-making facilities). For hospitals, the income approach usually carries the most weight because value lies in cash generation from medical operations.
Does a star doctor’s departure cut value?
Yes — sharply. A specialty clinic’s value often attaches to individuals: patients come for the doctor, not the clinic brand. Buyers must assess key-person risk: remaining contract terms, non-compete/non-solicitation clauses, and retention costs. A deal with no plan to keep pillar doctors deserves a deep discount.
Does the medical licence carry monetary value?
The operation licence is an intangible asset with real economic value — obtaining a new one costs time and money with uncertain outcomes, especially for deep specialties and high-tech procedures. In valuation, licence value shows through the cash flows its scope generates and through replacement cost. But it exists only while the facility stays compliant — lose the doctors or get partially suspended, and the licence value evaporates with it.
Frequently Asked Questions
Which method fits a small clinic?
Usually an earnings multiple (EBITDA) or revenue multiple on stable visit volumes, with net asset value as the floor. Small clinics have thin data, so buyers often push asset-based pricing.
How is a hospital brand valued?
Through the fee premium over market rates, patient return rates and replacement marketing cost. A strong brand commands higher service prices with full beds.
Should we hire an independent valuer?
Yes, especially with minority shareholders or related-party deals. A valuation certificate from a qualified valuation firm is objective grounding for negotiation and for tax-authority review of the deal price.
This article has been quality-reviewed by the FLAW AI Legal Council